Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986 Nov;45(11):941-4.
doi: 10.1136/ard.45.11.941.

Effect of treatment on erythrocyte phosphoribosyl pyrophosphate synthetase and glutathione reductase activity in patients with primary gout

J Braven, T R Hardwell, P Hickling, M Whittaker
Comparative Study

Effect of treatment on erythrocyte phosphoribosyl pyrophosphate synthetase and glutathione reductase activity in patients with primary gout

J Braven et al. Ann Rheum Dis. 1986 Nov.

Abstract

The activities of erythrocyte phosphoribosyl pyrophosphate (PRPP) synthetase and glutathione reductase (GTR) were studied in 26 patients with primary gout who were receiving no treatment or treatment with either allopurinol or azapropazone, and compared with the activity in a group of healthy controls. The activity of PRPP synthetase was significantly higher in the gout group and was not influenced by either drug. No significant difference in the activity of GTR was observed. The failure of either drug to suppress the increased activity of PRPP synthetase associated with gout is discussed.

PubMed Disclaimer

References

    1. Science. 1967 Feb 10;155(3763):712-3 - PubMed
    1. J Clin Pathol. 1970 Nov;23(8):708-10 - PubMed
    1. Ann Rheum Dis. 1971 Mar;30(2):134-7 - PubMed
    1. J Biol Chem. 1971 Sep 25;246(18):5739-48 - PubMed
    1. Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):703-6 - PubMed

Publication types